Hollywood writers' strike heats up as screen actors join the picket line
Former 'Law & Order' showrunner Warren Leight discusses the key issues for the writers and what's at stake on 'The Claman Countdown.'
Inflation is still hot, Fed has significant banking issues to navigate: Robert Heller
Global X ETFs CIO Jon Maier reacts to debt ceiling talks breaking down and former Federal Reserve Governor Robert Heller forecasts the Fed's next inflation move on 'The Claman Countdown.'
Success of Yellowstone, Boot Barn is 'hidden in plain sight': CEO Jim Conroy
Boot Barn President and CEO Jim Conroy discusses the 'giant consumer market' for Western-style apparel on 'The Claman Countdown.'
Fed risks a 'deeper, more protracted' recession with more rate hikes: Kevin Mahn
Meridian Equity Partners senior managing partner Jonathan Corpina and Hennion & Walsh Asset Management President and CIO Kevin Mahn discuss how debt ceiling drama is causing market volatility on 'The Claman Countdown.'
Teva's Richard Francis launches 'pivot to growth' strategy
Teva Pharmaceuticals CEO Richard Francis outlines his roadmap to accelerate growth on 'The Claman Countdown.'
Equity market volatility might pressure politicians to wrap up debt ceiling deal: Ross Mayfield
Baird investment strategy analyst Ross Mayfield weighs in on how debt ceiling talks are affecting the market and which stocks to avoid on 'The Claman Countdown.'
ERShares COO Eva Ados reveals the trick to having a balanced portfolio
ERShares COO Eva Ados pairs a 'safety' tech stock pick with a 'contrarian' pick on 'The Claman Countdown.'
Is it time to stop the comparison between Walmart and Target?
Telsey Advisory Group CEO Dana Telsey and Tigress Financial Partners CIO Ivan Feinseth discuss whether inflation is finally forcing consumers to pull back on spending on 'The Claman Countdown.'
You can invest like the financially-savvy Taylor Swift, too
RiverNorth Capital Management portfolio manager Steve O'Neill analyzes Taylor Swift's closed-end fund investment strategy on 'The Claman Countdown.'
Why investors turn to ETFs during DC's debt ceiling drama
Morgan Stanley senior vice president Jim Lacamp discusses how the debt debate is affecting markets and ETF Action founding partner Alex Shepard analyzes exchange-traded funds on 'The Claman Countdown.'
Investors would be wise to follow Warren Buffett's bank bets: Jon Najarian
Market Rebellion co-founder Jon Najarian and Seaport Securities founder Ted Weisberg discuss whether D.C.'s debt debacle is affecting Wall Street trading on 'The Claman Countdown.'
Commercial real estate must fix its debt problem to avoid same fate as SVB: Scott Rechler
RXR Realty Chairman and CEO Scott Rechler discusses solutions to the debt issues many U.S. commercial properties are facing on 'The Claman Countdown.'
Only way to solve debt crisis is to lead from the center: Rep. Josh Harder
Pennsylvania Republican Rep. Dan Meuser and California Democrat Rep. Josh Harder discuss solutions to the nation's debt crisis on 'The Claman Countdown.'
The crypto market is 'not a Republican oasis': Marco Santori
Kraken Exchange chief legal officer Marco Santori and FOX Business' Charlie Gasparino discuss Washington being torn over cryptocurrency and digital asset regulation.
Jeremy Siegel: Banking crisis is equal to three or four Fed rate hikes
SlateStone Wealth chief market strategist Kenny Polcari and Wharton School professor Jeremy Siegel discuss banks tightening lending standards after Fed rate hikes on 'The Claman Countdown.'
TYSON 2.0 partners with InterCure to bring high-quality cannabis to Israel, EU countries
Former professional boxer Mike Tyson and InterCure Chairman Ehud Barak discuss their deal to internationally distribute the boxing legend's marijuana on 'The Claman Countdown.'
Lemonade uses bots instead of brokers to collapse consumer costs: CEO Daniel Schreiber
Lemonade co-founder and CEO Daniel Schreiber explains how his insurance company uses AI to save customers money on 'The Claman Countdown.'
Tzar Labs creates breakthrough blood test that predicts tumors before they form
Tzar Labs founder and CEO Ashish Tripathi discusses the world's first pan-cancer early detection blood test on 'The Claman Countdown.'
Elon Musk naming a new Twitter CEO is great for Telsa: Ross Gerber
Gerber Kawasaki CEO Ross Gerber reacts to Elon Musk selecting NBC ad chief Linda Yaccarino to take over Twitter on 'The C
ChatGPT is a huge productivity enhancement tool for employees: Gerry Smith
ODP Corporation CEO Gerry Smith explains why the company expanded its collaboration with Microsoft to use its A.I. technology on 'The Claman Countdown.'